Term Name: (5Z,8Z,11Z,14Z,17Z)-icosapentaenoylethanolamine
Synonyms: (5Z,8Z,11Z,14Z,17Z)-eicosapentaenoyl ethanolamide, (5Z,8Z,11Z,14Z,17Z-eicosapentaenoyl) ethanolamine, (5Z,8Z,11Z,14Z17Z)-N-(2-hydroxyethyl)icosa-5,8,11,14,17-pentaenamide, all-cis-eicosa-5,8,11,14,17-pentaenoyl ethanolamide, all-cis-icosa-5,8,11,14,17-pentaenoyl ethanolamide, Anandamide (20:5, n-3), eicosapentaenoyl ethanolamide, EPEA, icosapentaenoyl ethanolamide, N-(5Z,8Z,11Z,14Z,17Z-eicosapentaenoyl)ethanolamine, N-cis-5,8, 11,14,17-eicosapentaenoylethanolamine
Definition: An N-acylethanolamine 20:5 that is the ethanolamide of (5Z,8Z,11Z,14Z17Z)-eicosapentaenoic acid.
Ontology: ChEBI [CHEBI:71467]  ( EBI )

Relationships
is a type of: endocannabinoid N-acylethanolamine 20:5
has_functional_parent: all-cis-5,8,11,14,17-icosapentaenoic acid
has_role: PPARgamma agonist